J1 👨👩👦👦 🇮🇹 🇺🇸 🇧🇪
1.7K posts

J1 👨👩👦👦 🇮🇹 🇺🇸 🇧🇪
@blessedpapa73
Espatriato. Liberista selvatico. Travel addict. Tifoso emotivo dei Niners. 🇮🇹🇺🇸🇧🇪







$IOVA - I don’t know how earnings will be but if you connect these dots, shorts maybe roasted tomorrow. 1. 5 year retrospective data showing amazing efficacy that was even better than clinical trials especially in patients who had two or fewer lines of treatments. 2. Key opinion leaders encouraging their peers to treat their patients with Amtagvi as soon as they progress from frontline. This is consistent with the National Comprehensive Cancer Network (NCCN). It is a not-for-profit alliance of 33 leading cancer centers such as MD Anderson, Memorial Sloan Kettering, and Mayo Clinic. The NCCN is widely considered the gold standard for cancer care because it develops the most frequently updated clinical practice guidelines in medicine. 3. Hirings: So many sales related positions were posted. This is shortly after the downsizing of 19%. Companies don’t start rehiring like this unless serious demand increases. 4. Another retrospective study shows greater efficacy for patients who received commercial Amtagvi (not clinical trial) reconfirms the 5 year retrospective study reported earlier last year. 5. More community hospitals and ATCs are coming and proudly announcing availability for TIL treatment. This will generate lots of revenue for hospitals AND $IOVA 6. Management has been EXTREMELY active at conferences. They are spreading the great news about Amtagvi and the next generation TIL. 7. Earnings being released in the morning. I was the first person to catch the change of time for earnings last quarter and I predicted earnings for Q3 would be good and it was. I believe this earnings report will even be better. Shorts will be roasted. 7. If $IOVA releases positive results on IOV-4001 the next Monday on March 2, shorts will be cooked I may not sleep at all. I may watch the men’s USA vs Canada hockey game over and over again. 😝























